Carl Zeiss Meditec (ETR:AFX) Stock Price Down 0.9% - Should You Sell?

Key Points

• Carl Zeiss Meditec AG saw its stock price decline by 0.9%, closing at €40.96 ($48.19), with trading volume up 129% compared to its average.
• The company has a market cap of $3.82 billion and a P/E ratio of 21.89, indicating investor expectations of growth.
• Carl Zeiss Meditec operates as a medical technology company specializing in ophthalmology and microsurgery, providing solutions for chronic eye diseases.

Carl Zeiss Meditec AG (ETR:AFX - )'s share price dropped 0.9% on Wednesday . The company traded as low as €40.52 ($47.67) and last traded at €40.96 ($48.19). Approximately 216,271 shares changed hands during mid-day trading, an increase of 129% from the average daily volume of 94,405 shares. The stock had previously closed at €41.32 ($48.61).

Carl Zeiss Meditec Trading Down 0.9%

The firm has a market cap of $3.82 billion, a P/E ratio of 21.89, a P/E/G ratio of 2.83 and a beta of 0.98. The business's 50-day moving average is €47.08 and its two-hundred day moving average is €55.03. The company has a debt-to-equity ratio of 7.41, a current ratio of 2.13 and a quick ratio of 2.47.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.